aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 16, 2025 16:01 ET | Source: aTyr Pharma, Inc. SAN DIEGO,…
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated…
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics…
Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq
CHICAGO, May 06, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health"…
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 02, 2025 16:42 ET | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British…
XORTX Announces Receipt of Nasdaq NotificationRegarding Minimum Bid Price Deficiency
April 17, 2025 19:45 ET | Source: XORTX Therapeutics Inc. CALGARY, Alberta,…
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 11, 2025 16:01 ET | Source: BridgeBio Pharma, Inc. PALO ALTO,…
WORK Medical Technology Group LTD Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Hangzhou, China, April 11, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group…
Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements
Raanana, Israel, April 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ)…
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 07, 2025 17:00 ET | Source: Anika Therapeutics Inc. BEDFORD, Mass.,…